Aarkstore Enterprise---uniting R&d And Marketing For Integrated Early-stage Market Preparation

Early-stage product commercialization continues to challenge even the most skilled and highly respected marketing and drug development organizations

. Changing government regulations, pharmacoeconomics, health care practices, and scientific innovations have transformed the drug development landscape in the past decade. As patent protection narrows on many companies top-selling brands, the race to market profitable products in record time is intensifying. These transformations have been met concurrently with rising drug development costs and diminishing R&D productivity.

These business drivers require organizational and cultural changes within drug companies in order to unite R&D and marketing - and to direct them toward shared objectives early in development. Injecting market input into drug discovery and early clinical development enables marketing and R&D to focus limited resources on the most promising drug candidates. With market information, R&D can develop drug target libraries and hone in on endpoints with the greatest likelihood of fulfilling unmet medical needs. Ultimately, a continuous exchange of information between R&D and marketing enables companies to make more informed portfolio decisions, to serve their markets better, and to achieve higher profits.

This report covers the critical areas in which R&D and marketing need to work together, including portfolio planning, resource allocation, product hand-offs and ownership, and project and product team structures. Best practices and case studies illustrate numerous tools, tactics, organizational structures and strategies used by top-performing pharmaceutical and biotech companies to bridge the gaps between R&D and marketing in early-stage drug development

Best practices and case studies illustrate a variety of tools, tactics, organizational structures and strategies used by top-performing pharmaceutical and biotech companies to bridge the gaps between R&D and marketing in early-stage drug development. This report covers all the critical areas in which R&D and marketing need to work together, including portfolio planning, resource allocation, product hand-offs and ownership, and project and product team structures.

Additional Information

Companies Included in Report Berlex

Biovail

Boehringer-Ingelheim

Bristol-Myers Squibb

Eli Lilly and Company

GTC Therapeutics

Merck & Co.

Novartis

Novo Nordisk

Otsuka America Pharmaceuticals

Pfizer

Procter & Gamble Pharmaceuticals

Sanofi-Aventis

For more information please contact :

http://www.aarkstore.com/reports/Uniting-R-D-and-Marketing-for-Integrated-Early-Stage-Market-Preparation-13912.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise

Contact: Neel

Email: press@aarkstore.com

URL: www.aarkstore.com

by: Aarkstore Enterprise

POST COMMENT

Zimbra Renders Integrated Email Solutions For Corporates Hardware Association: Simple Definition Of "aluminum On Behalf Of The Copper" Not Accurate Use Electric Radiant Floor To Enjoy The warmth Of Winters Grand Prize Is An Old Air Conditioning Supermarket Sweepstakes Too Far Plasma Lcd Stabilization Have Room For Growth To Accelerate Delisting Crt Suning Leveraging "the 51" Refrigerator, Washing Machine Into A Lead Economic Air Conditioning Efficient and Cost Effective Digital Label Press Finishing Insert The Electrical Adapter Into The Track Easy Methods To Create Gallery Designs From Digital Camera Images Hair Care With Hair Conditioner The Electric Meat Grinder A Buyers Guide? Your Custom Aluminum Real Estate Sign Doesn't Have To Blend In Digital Photography Business-Become the Go-To Pet Photographer In Your City